balabanovj

China Sky's Reported First Quarter Earnings Raise More Questions

I've read your articles on CSKI before and this one is especially groundless, so I 'm not going to spend any time addressing your points. I've done in-depth DD on this company and they are my top holding and are likely to remain in that position. Management is not perfect when it comes to following Wall Street rules, but they are learning fast. As for managing the day to day business, no Chinese pharma does it better! They're aggressive in persuing their market, conservative in their capex and other expenditures and the most shareholder friendly company I've come across.

James Balaban